- Home
- MDGL vs IT Comparison
MDGL vs IT Comparison
Compare MDGL & IT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | IT |
|---|---|---|
| Founded | 2011 | 1979 |
| Country | United States | United States |
| Employees | N/A | 40 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 12.2B |
| IPO Year | 2005 | 2010 |
Fundamental Metrics
Financial Performance| Metric | MDGL | IT |
|---|---|---|
| Price | $459.63 | $207.12 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 15 |
| Target Price | ★ $685.78 | $189.54 |
| AVG Volume (30 Days) | 254.0K | ★ 798.4K |
| Earning Date | 11-03-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.29 |
| Revenue | $180,133,000.00 | ★ $2,021,441,000.00 |
| Revenue This Year | $59.57 | N/A |
| Revenue Next Year | $38.84 | $4.02 |
| P/E Ratio | ★ N/A | $26.83 |
| Revenue Growth | N/A | ★ 13.30 |
| 52 Week Low | $393.61 | $124.25 |
| 52 Week High | $615.00 | $261.10 |
Technical Indicators
Market Signals| Indicator | MDGL | IT |
|---|---|---|
| Relative Strength Index (RSI) | 29.26 | 64.98 |
| Support Level | $455.42 | $142.37 |
| Resistance Level | $546.29 | $252.63 |
| Average True Range (ATR) | 16.54 | 6.00 |
| MACD | -4.18 | 1.53 |
| Stochastic Oscillator | 17.12 | 92.49 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About IT Gartner Inc.
Gartner provides independent research and analysis on information technology for chief information officers and other business executives who help plan companies' IT budgets. Its flagship Magic Quadrant reports inform many enterprises of their IT procurement decisions. Gartner also provides consulting services and holds some of the largest conferences in the IT industry. Around 80% of Gartner's revenue is generated from industry research.